GlassScriptPhysician profile
Melissa Lynn Paskey
NPI 1841580511
$3,957.02
in general payments reported to CMS, 2019-2025
21 companies · $3,147 in 2025
The $3,147 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.13 · 2020: $140 · 2021: $92.69 · 2022: $53.40 · 2023: $294 · 2024: $169 · 2025: $3,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $1,158 · Travel and Lodging: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $1,157.76 |
| Travel and Lodging | $952.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,066.28 | 2025 | |
| Astellas Pharma US INC | $114.05 | 2023-2024 | Veozah |
| Exeltis, USA INC. | $112.37 | 2020-2024 | Slynd |
| Abbvie INC. | $107.81 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Mayne Pharma Commercial LLC | $81.89 | 2023-2025 | |
| Organon LLC | $67.81 | 2023-2025 | Nexplanon |
| Baxter Healthcare | $63.16 | 2019-2021 | |
| Pfizer INC. | $46.90 | 2020-2023 | |
| Mylan Pharmaceuticals INC. | $41.84 | 2020-2021 | |
| Agile Therapeutics, INC. | $33.53 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $32.32 | 2023-2024 | Gemtesa, Myfembree |
| Exact Sciences Corporation | $29.95 | 2024-2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $25.05 | 2024 | |
| Coloplast Corp | $21.93 | 2023 | Altis |
| Minerva Surgical, INC | $19.50 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $16.20 | 2024 | |
| Conmed Corporation | $15.91 | 2020 | |
| Merck Sharp & Dohme LLC | $15.54 | 2024 | Gardasil, Gardasil 9 |
| Shield Therapeutics INC | $15.29 | 2023 | Accrufer |
| Therapeuticsmd, INC. | $15.10 | 2022 | |
| Duchesnay USA Incorporated | $14.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Paskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.